Jenny Phan
Katy, TXNPI 1124568225
Payments from drug & device makers
Across 378 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$843
- Bayer$693
- Abbott$654
- Optinose US, Inc.$527
- Biohaven Pharmaceutical Holding Company Ltd.$510
- plus $3K from 19 others
What the payments were for
- Food & beverage$7,737100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 70 | $1,471 |
| Novo Nordisk | 29 | $843 |
| Bayer | 32 | $693 |
| Abbott | 57 | $654 |
| Optinose US, Inc. | 29 | $527 |
| Biohaven Pharmaceutical Holding Company Ltd. | 24 | $510 |
| AstraZeneca | 10 | $466 |
| Biohaven Pharmaceuticals, Inc. | 18 | $455 |
| Lilly USA, LLC | 21 | $381 |
| Amarin Pharma, Inc. | 24 | $359 |
| Boehringer Ingelheim | 9 | $226 |
| Amgen(2 entities) | 10 | $163 |
| Esperion Therapeutics, Inc. | 6 | $140 |
| Pfizer | 7 | $131 |
| GSK | 8 | $130 |
| Merck | 3 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $111 |
| Sanofi-aventis U.S. LLC | 4 | $97 |
| Corium, LLC | 4 | $96 |
| Eisai Inc. | 3 | $64 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Merz Pharmaceuticals, LLC | 1 | $31 |
| Nevro Corp. | 1 | $27 |
| Exact Sciences | 1 | $14 |
| Genentech USA, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 55 | $351 |
| Montelukast Sodium | 15 | $234 |
| Levothyroxine Sodium | 15 | $216 |
| Rosuvastatin Calcium | 17 | $194 |
| Losartan Potassium | 17 | $144 |
| Gabapentin | 12 | $136 |
| Amlodipine Besylate | 23 | $102 |
| Lisinopril | 17 | $81 |
| Metformin Hcl | 14 | $80 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.